Yu W - Search Results

1

Biodegradable persistent ROS-generating nanosonosensitizers for enhanced synergistic cancer therapy by inducing cascaded oxidative stress.

Chen Y, Ding T, Qian Z, Ma Z, Zhou L, Li Z, Lv R, Xu Y, Xu Y, Hao L, Zhu C, Yao X, Yu W, Fan W. Chen Y, et al. Among authors: yu w. Nanoscale Horiz. 2024 Sep 19. doi: 10.1039/d4nh00189c. Online ahead of print. Nanoscale Horiz. 2024. PMID: 39295580

2

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy.

He Q, Zhou L, Yu D, Zhu R, Chen Y, Song M, Liu X, Liao Y, Ding T, Fan W, Yu W. He Q, et al. Among authors: yu d, yu w. J Med Chem. 2023 Aug 10;66(15):10458-10472. doi: 10.1021/acs.jmedchem.3c00587. Epub 2023 Jun 6. J Med Chem. 2023. PMID: 37279091

3

ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy.

Zhu R, He Q, Li Z, Ren Y, Liao Y, Zhang Z, Dai Q, Wan C, Long S, Kong L, Fan W, Yu W. Zhu R, et al. Among authors: yu w. Acta Biomater. 2022 Nov;153:442-452. doi: 10.1016/j.actbio.2022.09.061. Epub 2022 Sep 28. Acta Biomater. 2022. PMID: 36179978

4

Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2.

Yu W, Zhao Y, Ye H, Wu N, Liao Y, Chen N, Li Z, Wan N, Hao H, Yan H, Xiao Y, Lai M. Yu W, et al. J Med Chem. 2022 Dec 22;65(24):16252-16267. doi: 10.1021/acs.jmedchem.2c00954. Epub 2022 Dec 12. J Med Chem. 2022. PMID: 36503248

5

Real-time monitoring of etoposide prodrug activated by hydrogen peroxide with improved safety.

Zhu J, Chen J, Song D, Zhang W, Guo J, Cai G, Ren Y, Wan C, Kong L, Yu W. Zhu J, et al. Among authors: yu w. J Mater Chem B. 2019 Dec 21;7(47):7548-7557. doi: 10.1039/c9tb02041a. Epub 2019 Nov 13. J Mater Chem B. 2019. PMID: 31720667

6

Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors.

Guo J, Yu W, Cai G, Zhang W, Li S, Zhu J, Song D, Kong L. Guo J, et al. Among authors: yu w. Eur J Med Chem. 2018 May 10;151:752-764. doi: 10.1016/j.ejmech.2018.03.053. Epub 2018 Apr 4. Eur J Med Chem. 2018. PMID: 29674294

7

A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy.

Zhang W, Yu W, Cai G, Zhu J, Zhang C, Li S, Guo J, Yin G, Chen C, Kong L. Zhang W, et al. Among authors: yu w. Cell Death Dis. 2018 Oct 27;9(11):1098. doi: 10.1038/s41419-018-1139-z. Cell Death Dis. 2018. Retraction in: Cell Death Dis. 2021 May 21;12(6):522. doi: 10.1038/s41419-021-03809-2. PMID: 30368518 Free PMC article. Retracted.

8

Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors.

Cai G, Yu W, Song D, Zhang W, Guo J, Zhu J, Ren Y, Kong L. Cai G, et al. Among authors: yu w. Eur J Med Chem. 2019 Jul 15;174:236-251. doi: 10.1016/j.ejmech.2019.04.024. Epub 2019 Apr 16. Eur J Med Chem. 2019. PMID: 31048139

9

Near-Infrared Fluorescent Probe with Remarkable Large Stokes Shift and Favorable Water Solubility for Real-Time Tracking Leucine Aminopeptidase in Living Cells and In Vivo.

Zhang W, Liu F, Zhang C, Luo JG, Luo J, Yu W, Kong L. Zhang W, et al. Among authors: yu w. Anal Chem. 2017 Nov 21;89(22):12319-12326. doi: 10.1021/acs.analchem.7b03332. Epub 2017 Oct 30. Anal Chem. 2017. PMID: 29048879

10

Sacubitril Ameliorates Cardiac Fibrosis Through Inhibiting TRPM7 Channel.

Jia T, Wang X, Tang Y, Yu W, Li C, Cui S, Zhu J, Meng W, Wang C, Wang Q. Jia T, et al. Among authors: yu w. Front Cell Dev Biol. 2021 Oct 29;9:760035. doi: 10.3389/fcell.2021.760035. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34778271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,331 results

Search Page

Filters